Infant Formula Recall: Class Action Suit Claims Nara Organics Failed To Disclose Bacterial Contamination

New to ClassAction.org? Read our Newswire Disclaimer

A proposed class action lawsuit claims that Nara Organics falsely represented its infant formula as safe despite its alleged contamination with certain bacteria that can be life-threatening to infants, prompting a June 2026 recall.

Want to stay in the loop on class action lawsuits that matter to you? Sign up for ClassAction.org’s free weekly newsletter.

The 21-page complaint contends that Nara Organics “improperly, deceptively, and misleadingly” marketed its infant formula by failing to disclose that the product was contaminated with Clostridium botulinum, the bacterium responsible for infant botulism.

According to the lawsuit, exposure to Clostridium botulinum can lead to potentially fatal health complications in infants because the bacterium can colonize in the immature intestinal tract and produce dangerous neurotoxins. Per the filing, infant botulism may result in constipation, poor feeding, lethargy, low muscle tone, difficulty sucking and swallowing, weakness and respiratory distress.

The case says that Nara Organics recalled its infant formula on June 12, 2026, due to the apparent contamination and associated health risks.

According to the complaint, consumers in search of refunds under the recall program must still possess the affected product. However, the lawsuit alleges that Nara Organics is “well aware” that many consumers would likely discard the recalled formula immediately after learning of the contamination.

The filing also mentions that many consumers do not habitually retain receipts and may purchase formula from multiple retailers, making it difficult to obtain reimbursement from the point of sale.

As a result, the class action lawsuit argues, the infant formula recall was “deliberately designed to preclude the vast majority of consumers” from receiving compensation.

Related Reading: ‘Insufficient’ ByHeart Recall of Contaminated Infant Formula Benefits Very Few Consumers, Class Action Alleges

The suit further contends that Nara Organics knew or should have known about the risk of bacterial contamination long before the recall because, as the manufacturer, it was uniquely positioned to test and monitor its products before they entered the stream of commerce.

Despite the alleged contamination risk, Nara Organics led consumers to believe the formula was safe for consumption and failed to disclose any contamination concerns on the product’s packaging or in advertising campaigns, the complaint maintains. As a result, consumers reasonably relied on the company’s representations when making purchasing decisions and paid a premium price for a formula they believed was free of harmful ingredients, the case alleges.

The Nara Organics class action lawsuit looks to represent all consumers who purchased Nara Organics infant formula in the United States during the applicable statute of limitations period.

Check out ClassAction.org’s lawsuit list for the latest top class action lawsuits.